API Suppliers
US DMFs Filed
0
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
Details:
The grant will be used to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone.
Lead Product(s): KMN-159,Collagen
Therapeutic Area: Musculoskeletal Product Name: KMN-159
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: NIDCR
Deal Size: $1.7 million Upfront Cash: Undisclosed
Deal Type: Funding September 16, 2021
Details:
New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.
Lead Product(s): Hyaluronic Acid,Dermatan Sulfate,Collagen
Therapeutic Area: Dermatology Product Name: Dermial
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable May 25, 2022
Details:
Dermal Repair Complex helps combat the key causes of dermal breakdown — resulting in visibly firmer and more lifted skin, reduced wrinkles, enhanced radiance, and a significantly younger, healthier overall appearance.
Lead Product(s): Dimethyl Sulfone,Hyaluronic Acid,Collagen
Therapeutic Area: Dermatology Product Name: Dermal Repair Complex
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 28, 2022